Cita APA

Garcia‑Campelo, R., Casal Rubio, J., Martínez Marti, A., Insa, A., Provencio, M., Nadal, E., & Serna-Blasco, R. (2022). Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).

Citación estilo Chicago

Garcia‑Campelo, Rosario, Joaquín Casal Rubio, Alexandre Martínez Marti, Amelia Insa, Mariano Provencio, Ernest Nadal, y Roberto Serna-Blasco. Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM Phase II Trial). 2022.

Cita MLA

Garcia‑Campelo, Rosario, et al. Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM Phase II Trial). 2022.